News
BrainStorm has attempted to gain market approval for NurOwn without success but remains committed to developing the cell therapy.
Euro telcos issues subsea security pleaTelefónica shareholders welcome new CEOT-Mobile US to test 7GHz wireless gear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback